Stockreport

ESTEVE signs a licensing agreement for a severe primary insulin-like growth factor 1 deficiency treatment [Yahoo! Finance]

Eton Pharmaceuticals, Inc.  (ETON) 
Last eton pharmaceuticals, inc. earnings: 3/5 04:02 pm Check Earnings Report
PDF The acquisition of the treatment for this rare disease is an example of ESTEVE's commitment focused on growth opportunities in high unmet medical and patient needs. B [Read more]